MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 69975-86-6
MCE 国际站:Doxofylline
产品活性:Doxofylline 是一种口服有效的 PDE IV 抑制剂,也是 A1AR 拮抗剂。Doxofylline 通过抑制线粒体 ROS 的产生,以及改善多种细胞途径 (包括 NLRP3-TXNIP 炎症体的激活) 来减轻上皮细胞的炎症。Doxophylline 可用于哮喘、慢性阻塞性肺病和支气管痉挛的研究。
研究领域:GPCR/G Protein | Metabolic Enzyme/Protease | Immunology/Inflammation | NF-κB
作用靶点:Adenosine Receptor | Phosphodiesterase (PDE) | Reactive Oxygen Species
In Vitro: Doxofylline (5, 10 µM; 48 h) shows potent protection against LPS-induced epithelial inflammation by reducing PGE2, NO release, and decreasing mitochondrial ROS generation in 16HBE cells.
Doxofylline (5, 10 µM; 48 h) suppresses LPS-induced expression of NADPH oxidase subunits and TXNIP 16HBE cells.
Doxofylline (5, 10 µM; 48 h) inhibits LPS-induced NLRP3 inflammasome activation and secretion of IL-1b and IL-18, as well as mitigates LPS-mediated SIRT1 reduction.
Doxofylline (0.1-10 µM; 15 min) significantly reduces fMLP-induced leukocyte migration in BM cells (fMLP: Formyl-Methionyl-Leucyl-Phenylalanine).
In Vivo: Doxofylline (0.3, 1 mg/kg; i.p.; single) inhibits LPS-induced inflammation in the lungs of mice.
Doxofylline (0.3 mg/kg; i.p.; pre-treat; single) notably reduces the adhesion of cells to the vascular tissue and surpresses the expression of LPS-induced ICAM-1 in vivo.
相关产品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Immunology/Inflammation Compound Library | Metabolism/Protease Compound Library | NF-κB Signaling Compound Library | Stem Cell Signaling Compound Library | FDA-Approved Drug Library | Small Molecule Immuno-Oncology Compound Library | Anti-Aging Compound Library | Drug Repurposing Compound Library | Antioxidant Compound Library | Reprogramming Compound Library | Oxygen Sensing Compound Library | Ferroptosis Compound Library | Anti-COVID-19 Compound Library | NMPA-Approved Drug Library | Pyroptosis Compound Library | Orally Active Compound Library | Neurotransmitter Receptor Compound Library | FDA Approved & Pharmacopeial Drug Library | Anti-Alzheimer's Disease Compound Library | Anti-Parkinson's Disease Compound Library | Neurodegenerative Disease-related Compound Library | Mitochondria-Targeted Compound Library | Rare Diseases Drug Library | Anti-Colorectal Cancer Compound Library | Antidepressant Compound Library | Human Metabolite Library | Off-patent Drug Library | Mitochondrial Protection Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | D-α-Hydroxyglutaric acid disodium | 8α-Tigloyloxyhirsutinolide 13-O-acetate | Cirsimarin | PDE11-IN-1 | Anticancer agent 120 | 7-Hydroxy-4-methyl-2(1H)-quinolone | Enpp-1-IN-2 | PAT-347 | Vardenafil-d5 | N-tert-Butyl-α-phenylnitrone-d14 | BDP 581/591 NHS ester | Bay 60-7550 | Cysteamine-d4 hydrochloride | 2-Chloro-N-cyclopentyl-2′-C-methyladenosine | Deltarasin hydrochloride | HA155 | Apremilast | Enpp-1-IN-6 | MRS-1191 | L-Ascorbic acid sodium salt | Roflumilast | RS-25344 hydrochloride | Manganese(salen) chloride | APNEA | HEMADO | Hydroxyphenyl Fluorescein | A2A receptor antagonist 2 | PDE4-IN-6 | Glucosamine sulfate | Maresin 1
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种全球独家化合物库,我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。